Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)
Clinical trial NCT05266430 · TERMINATED
Trial details
- NCT number
- NCT05266430
- Sponsor
- Aura Biosciences
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-14
- Primary completion
- 2023-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.